Completed NA INTERVENTIONAL 1-arm NCT03598452

High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients

A Prospective, Non-randomized, Non-controlled Trial: Initial Intravitreal Injection of High-dose Ganciclovir for Cytomegalovirus Retinitis in HIV-negative Patients

Sponsor: Aier School of Ophthalmology, Central South University

Conditions Infection Viral Uveitis, Posterior

Interventions Ganciclovir

Updated 4 times since 2018 Last updated: Jul 24, 2018 Started: Jan 31, 2014 Primary completion: Jan 31, 2018 Completion: Jun 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Infection Viral and Uveitis, Posterior and is currently completed. Aier School of Ophthalmology, Central South University leads this study, which shows 4 recorded versions since 2014 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Aug 2018 — Jan 2021 [monthly]

Completed NA

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aier School of Ophthalmology, Central South University

Data source: Aier School of Ophthalmology, Central South University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.